The Fifteenth Annual Independent Medical Education and Grants Breakthrough Summit will be held September 12 through 13, 2017 at the Sonesta Hotel in Philadelphia, Pennsylvania. The event promises to bring together supporting organizations, medical education providers, and other key stakeholders to address some of the industry-leading issues.
Attendees will gain the latest insights on how to: assess the opportunities for medical education in a value-based healthcare landscape; evaluate and weigh the benefits versus costs to incorporate innovative learning formats and the latest technologies into CME; partner with patient advocacy groups to improve the value and effectiveness of IME programs; and communicate the value of CME to internal stakeholders.
On Tuesday, September 12, 2017, the day opens with a continental breakfast, followed by a welcome and opening remarks by Mike LoPresti of the Global Academy for Medical Education. Andrew Rosenberg with the CME Coalition will then present a Washington Healthcare Update. After a few other presentations and a networking rbeak, the first panel will form, “Patient Advocacy Groups 101 – Understanding How Patient Advocacy Groups Function and their Role in the Healthcare Industry,” with panelists including Stephen Chavez of Health Advocacy Partners, Jennifer Mefford of the Pulmonary Fibrosis Foundation, and Gina Ross Murdoch with the Multiple Sclerosis Association of America. The afternoon will have several workshop offerings, including “Creating More Impactful Reports and Communications,” “Telemedicine – The Next Big Thing in CME and QIE,” and “Innovating in Traditional CME Offerings.” The day ends with a networking, wine and cheese reception.
On Wednesday, the day starts again with a panel on “Shared Risk, Reduced Costs and Improved Outcomes – What’s the Role of CME in Value-based Healthcare,” with panelists Molly Mooney with the Cleveland Clinic, Michael Reilly of Regeneron Pharmaceuticals, and Karyn Ruiz-Cordell of RealCME. Several other panels and a networking lunch will preclude the final panel, “Grants Review – The Art of Crafting Quality Grant Applications.” The final panel will include thoughts from Ann Marie DeMatteo of Regeneron Pharmaceuticals, Samantha Koth of Sunovion Pharmaceuticals, Derek Warnick of Pfizer Inc., and Greselda Butler of Otsuka Pharmaceutical Development and Commercialization, Inc.
Policy and Medicine readers can save $300 on registration by using the code IMEPM3. The discount applies to standard rates only and may not be combined with other offers, category rates, promotions or applied to an existing registration. Offer not valid on academic or non-profit registrations.